ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS: ZIVO · Delayed Price · USD
6.90
0.00 (0.00%)
Apr 18, 2024, 11:06 AM EDT - Market open
ZIVO Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 0.27 | 1.8 | 8.9 | 0.14 | 0.35 | 0.39 | 0.32 | 0.51 | 0.02 | 0 | Upgrade
|
| Cash & Cash Equivalents | 0.27 | 1.8 | 8.9 | 0.14 | 0.35 | 0.39 | 0.32 | 0.51 | 0.02 | 0 | Upgrade
|
| Cash Growth | -84.75% | -79.79% | 6357.09% | -60.17% | -11.00% | 22.63% | -37.45% | 2956.16% | 1099.49% | -99.72% | Upgrade
|
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Assets | 0.15 | 0.1 | 0.06 | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.03 | Upgrade
|
| Total Current Assets | 0.43 | 1.9 | 8.96 | 0.17 | 0.37 | 0.41 | 0.33 | 0.52 | 0.03 | 0.03 | Upgrade
|
| Property, Plant & Equipment | 0.1 | 0.19 | 0.03 | 0.05 | 0 | 0 | 0 | 0.02 | 0.04 | 0.07 | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.03 | 0 | 0 | 0 | 0 | 3.88 | 0.2 | 0 | 0 | Upgrade
|
| Total Long-Term Assets | 0.13 | 0.22 | 0.03 | 0.05 | 0 | 0 | 3.88 | 0.22 | 0.04 | 0.07 | Upgrade
|
| Total Assets | 0.56 | 2.12 | 8.99 | 0.22 | 0.37 | 0.41 | 4.21 | 0.74 | 0.07 | 0.1 | Upgrade
|
| Accounts Payable | 0.99 | 0.49 | 0.65 | 1.56 | 1.37 | 0.42 | 0.54 | 0.67 | 1.33 | 1.23 | Upgrade
|
| Deferred Revenue | -0.24 | 0 | 0 | 1.94 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Current Debt | 0.35 | 0.34 | 0.26 | 5.22 | 5.28 | 18.15 | 1.88 | 7.13 | 1.56 | 3.77 | Upgrade
|
| Other Current Liabilities | 1.66 | 1.2 | 2.04 | 2.68 | 2.06 | 4.12 | 2.14 | 3.38 | 2.08 | 1.24 | Upgrade
|
| Total Current Liabilities | 2.76 | 2.03 | 2.95 | 11.39 | 8.71 | 22.69 | 4.56 | 11.18 | 4.97 | 6.23 | Upgrade
|
| Long-Term Debt | 0 | 0.11 | 0 | 0.14 | 0 | 0 | 15.95 | 3.18 | 4.6 | 0.24 | Upgrade
|
| Other Long-Term Liabilities | 0 | 0 | 0 | 0 | 0 | 18.58 | 0 | 0 | 0 | 0 | Upgrade
|
| Total Long-Term Liabilities | 0 | 0.11 | 0 | 0.14 | 0 | 18.58 | 15.95 | 3.18 | 4.6 | 0.24 | Upgrade
|
| Total Liabilities | 2.76 | 2.13 | 2.95 | 11.53 | 8.71 | 22.69 | 20.51 | 14.36 | 9.57 | 6.47 | Upgrade
|
| Total Debt | 0.35 | 0.45 | 0.26 | 5.36 | 5.28 | 18.15 | 17.84 | 10.31 | 6.16 | 4.01 | Upgrade
|
| Debt Growth | -22.20% | 74.46% | -95.24% | 1.42% | -70.91% | 1.78% | 73.04% | 67.34% | 53.76% | 59.61% | Upgrade
|
| Common Stock | 0 | 0.01 | 0.01 | 0.41 | 0.4 | 0.18 | 0.14 | 0.14 | 0.13 | 0.13 | Upgrade
|
| Retained Earnings | -123.58 | -115.8 | -108.23 | -99.06 | -89.96 | -78.45 | -63.81 | -53.77 | -47.71 | -41.93 | Upgrade
|
| Comprehensive Income | 0 | 0 | 0 | 0 | 0 | -0.1 | -0.1 | -0.08 | -0.06 | -0.03 | Upgrade
|
| Shareholders' Equity | -2.21 | -0.01 | 6.04 | -11.31 | -8.34 | -22.28 | -16.3 | -13.62 | -9.5 | -6.37 | Upgrade
|
| Total Liabilities and Equity | 0.56 | 2.12 | 8.99 | 0.22 | 0.37 | 0.41 | 4.21 | 0.74 | 0.07 | 0.1 | Upgrade
|
| Net Cash / Debt | -0.07 | 1.35 | 8.65 | -5.22 | -4.93 | -17.77 | -17.52 | -9.8 | -6.14 | -4.01 | Upgrade
|
| Net Cash / Debt Growth | - | -84.34% | - | - | - | - | - | - | - | - | Upgrade
|
| Net Cash Per Share | -0.04 | 0.86 | 6.80 | -6.17 | -8.57 | -54.43 | -60.40 | -35.15 | -22.52 | -10.55 | Upgrade
|
| Working Capital | -2.34 | -0.13 | 6.01 | -11.23 | -8.34 | -22.28 | -4.23 | -10.66 | -4.94 | -6.2 | Upgrade
|
| Book Value Per Share | -1.27 | -0.01 | 4.76 | -13.37 | -14.48 | -68.26 | -56.20 | -48.85 | -34.81 | -16.78 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.